Abstract
Clinical Pharmacology & TherapeuticsVolume 74, Issue 5 p. 403-405 Commentary American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra Alan S. Hollister MD, PhD, Alan S. Hollister MD, PhD Past-Chairman ASCPT Government Affairs CommitteeSearch for more papers by this authorGregory L. Kearns PharmD, PhD, Corresponding Author Gregory L. Kearns PharmD, PhD President ASCPTDivision of Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics, 2401 Gillham Rd, Kansas City, MO 64108, USA. E-mail: gkearns@cmh.eduSearch for more papers by this author Alan S. Hollister MD, PhD, Alan S. Hollister MD, PhD Past-Chairman ASCPT Government Affairs CommitteeSearch for more papers by this authorGregory L. Kearns PharmD, PhD, Corresponding Author Gregory L. Kearns PharmD, PhD President ASCPTDivision of Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics, 2401 Gillham Rd, Kansas City, MO 64108, USA. E-mail: gkearns@cmh.eduSearch for more papers by this author First published: 27 November 2003 https://doi.org/10.1016/S0009-9236(03)00236-4Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume74, Issue5November 2003Pages 403-405 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
